SCHEMBL191583

SCHEMBL191583

Fc1cccc(F)c1Oc1cc(Cl)nc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 3/20 0.39
GCK P35557 3/20 0.38
DHODH Q02127 1/20 0.35
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34
SLC6A2 P23975 5/20 0.33
HTR1A P08908 4/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
EGLN2 Q96KS0 1/20 0.33
PPARG P37231 1/20 0.32
LPAR1 Q92633 2/20 0.32
LPAR5 Q9H1C0 2/20 0.32
EPAS1 Q99814 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190888 0.80 GCK (0.51) GCKPOLBHSP90AA1MAPTSLC6A2
SCHEMBL10882722 0.79 ALDH1A1 (0.44) S1PR2GCKSLC6A2HTR1ASLC6A3
SCHEMBL192178 0.74 GCK (0.42) GCKPOLBMAPTMEN1KMT2A
SCHEMBL17413516 0.71 LTA4H (0.55) S1PR2MAPTMEN1KMT2A
SCHEMBL16415975 0.71 SLC6A2 (0.45) GCKSLC6A2HTR1ASLC6A4SLC6A3
SCHEMBL2925367 0.71 GCK (0.43) GCKPOLBHSP90AA1MAPTSLC6A2
SCHEMBL2052978 0.67 HTR1A (0.33) GCKSLC6A2HTR1ASLC6A4SLC6A3
SCHEMBL10879583 0.67 ALDH1A1 (0.46) SLC6A2SLC6A4SLC6A3KMT2A
SCHEMBL19602282 0.67 POLB (0.43) GCKPOLBHSP90AA1MAPTSLC6A2
SCHEMBL19602281 0.67 MAPT (0.72) GCKPOLBHSP90AA1MAPTSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 S1PR2 3484/4885GCK 2/4885DHODH 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.